Cargando…

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome

Women with polycystic ovary syndrome (PCOS) show high prevalence of glucose intolerance. This study aimed to investigate the association of androgen excess with glucose intolerance in PCOS. A total of 378 women with PCOS participated in the study. Free androgen index (FAI) was selected as indicator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bingjie, Wang, Jing, Shen, Shanmei, Liu, Jiayi, Sun, Jie, Gu, Tianwei, Ye, Xiao, Zhu, Dalong, Bi, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863307/ https://www.ncbi.nlm.nih.gov/pubmed/29707577 http://dx.doi.org/10.1155/2018/6869705

Ejemplares similares

Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
por: Karakas, Sidika E., et al.
Publicado: (2010)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
por: Kępczyńska-Nyk, A., et al.
Publicado: (2020)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome
por: Chen, Jie, et al.
Publicado: (2015)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome
por: Song, Linyi, et al.
Publicado: (2022)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
por: Yuan, Chun, et al.
Publicado: (2016)

The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2012)

Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study
por: Ng, Noel Yat Hey, et al.
Publicado: (2019)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Androgen levels in the fetal cord blood of children born to women with polycystic ovary syndrome: a meta-analysis
por: Duan, Changling, et al.
Publicado: (2020)

Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats
por: Zhai, Hua-Ling, et al.
Publicado: (2012)

Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
por: Kumarendran, Balachandran, et al.
Publicado: (2018)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome
por: Kushnir, Vitaly A., et al.
Publicado: (2015)

Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome
por: Mizgier, Małgorzata, et al.
Publicado: (2021)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

OR20-01 Machine Learning-based Steroid Metabolome Analysis In Women With Polycystic Ovary Syndrome Reveals Three Distinct Androgen Excess Subtypes With Different Metabolic Risk Profiles.
por: Rocha, Thaís P, et al.
Publicado: (2023)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

Erythropoietin Inhibits Gluconeogenesis and Inflammation in the Liver and Improves Glucose Intolerance in High-Fat Diet-Fed Mice
por: Meng, Ran, et al.
Publicado: (2013)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Androgen Receptor CAG Repeat Polymorphism and Epigenetic Influence among the South Indian Women with Polycystic Ovary Syndrome
por: Dasgupta, Shilpi, et al.
Publicado: (2010)

Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia
por: Ghaneei, Azam, et al.
Publicado: (2015)

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2017)

The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
por: Ghanbarzadeh-Ghashti, Niloofar, et al.
Publicado: (2023)

Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome
por: Kwon, Seeun, et al.
Publicado: (2023)

Vitamin D deficiency in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2014)

Androgen Excess Increases Food Intake in a Rat Polycystic Ovary Syndrome Model by Downregulating Hypothalamus Insulin and Leptin Signaling Pathways Preceding Weight Gain
por: Liu, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lh25fl6pb1jncb96b26auscg4g